SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK824.50m
- SEK751.38m
- SEK200.23m
Brief: Sedana Medical Q3 EBIT Loss Widens To SEK 5.1 Mln
Brief: Sedana Medical Says Board Member Michael Ryan Resigns
Brief: Sedana Medical Adjusts, Clarifies Long-Term Financial Targets
Brief: Sedana Medical Raises SEK 375 Mln In Directed Share Issue
Brief: Sedana Medical Prepares For Listing On The Nasdaq Stockholm Main Market
Brief: Sedana Medical AB Intends To Undertake A Directed New Share Issue
Brief: Sedana Medical: AnaConDa Approved For Use In Children
Brief: Sedana Medical Q2 EBITDA Loss Widens To Sek 2.3 Million
Brief: Sedana Medical Q2 EBITDA Loss Widens To SEK 2.33 Mln
Brief: Sedana Medical Signs Agreement With Indian Distributor
Brief: Sedana Medical Signs Distribution Deal With Chinese Distributor
Brief: Sedana Medical Q1 EBITDA Loss Widens To SEK 2.6 Million
Brief: Sedana Medical: FDA Positive About Combination Registration Of Isoconda And Anaconda In US
Brief: Sedana Medical Q4 EBIT Loss Widens To 2.5 Mln
Brief: Sedana Medical: Positive Interim Analysis In Pivotal IsoConDa Phase III Study
Brief: Sedana Medical Receives Go-Ahead For Pediatric Study
Brief: Sedana Medical Q3 EBITDA Loss At SEK 1.0 Million
Brief: Sedana Medical Receives Approval For AnaConDa In Japan
Brief: Sedana Medical Broadens Shareholder Base